Orthopedic Biomaterials Market in the U.S. to Reach Almost $6.3 Billion by 2016

Hyaluronic Acid Market to Almost Double in Size

VANCOUVER, Feb. 16 /PRNewswire/ - According to a new global report series by
iData Research (www.idataresearch.net), the leading authority in medical
device, dental and pharmaceutical market research, the U.S. market for
orthopedic biomaterials grew by 11.5% in 2009 and is estimated to reach almost
$6.3 billion by 2016. The market for orthopedic hyaluronic acid
viscosupplementation (HA) in 2009 increased almost 30% over the previous year
due to growth in the market for three-injection-cycle products. The report
states that the launch of single-injection-products will stimulate market
growth for HA therapies, while the aging population and increased incidence of
osteoarthritis will drive the overall market for orthopedic biomaterials.

Orthopedic biomaterials are implanted or applied in or near bone to facilitate
healing. This procedure fills in areas where bone tissue is depleted to
restore structure and allow for repair, leading to bone augmentation. Some of
the fastest-growing market segments include orthopedic stem cells and
cartilage repair. In addition, the market for HA is estimated to see
significant changes, due to the FDA approval of Genzyme Biosurgery's
single-injection product, SynviscOne(R).

"The introduction of single-injection-cycle products in 2009 is attracting new
patients to the viscosupplementation market and cannibalizing market shares
for existing products," says Dr. Kamran Zamanian, CEO of iData. "Competition
is expected to intensify, putting pressure on pricing and influencing
procedural volumes."

iData's global series on the Markets for Orthopedic Biomaterials 2010 includes
comprehensive analyses of the markets for:

Growth Factor Therapy
Bone Graft Substitutes
Machined Bone Allografts
Hyaluronic Acid Viscosupplementation
Resorbable Tissue and Bone Fixation Devices
Tendon Allografts
Cartilage Repair
Platelet and Bone Marrow Concentration
Stem Cell Therapy

The report series also includes comprehensive competitive analyses, which
cover companies such as Biomet, DePuy, Genzyme, Medtronic, NuVasive, Sanofi
Aventis, Smith & Nephew and Synthes, among others.

For more information, register free on iData's website at:
http://www.idataresearch.net/idata/registration.php

Or visit us at Booth 6249 at AAOS 2010

About iData Research

iData Research (www.idataresearch.net/idata/discoveridata.php) is an
international market research and consulting group focused on providing market
intelligence for medical device, dental and pharmaceutical companies. iData
covers research in: orthopedic biomaterials, orthopedic trauma, soft tissue,
spinal implants, wound management, endoscopy, cardiovascular, dental,
pharmaceuticals and more.

SOURCE iData Research Inc.

Drew Gutschmidt, (604) 266-6933, drew@idataresearch.net